Benitec Biopharma Inc.

NASDAQ: BNTC · Real-Time Price · USD
12.93
0.27 (2.13%)
At close: Aug 15, 2025, 3:59 PM
11.05
-14.54%
After-hours: Aug 15, 2025, 07:55 PM EDT

Benitec Biopharma Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
-21.75M -19.56M -18.21M -13.88M
Depreciation & Amortization
343K 381K 392K 424K
Stock-Based Compensation
830K 452K 870K 634K
Other Working Capital
233K 714K 1.04M 8K
Other Non-Cash Items
1K 717K 10K -16K
Deferred Income Tax
n/a -714K n/a n/a
Change in Working Capital
1.17M 714K 1.04M 8K
Operating Cash Flow
-19.4M -18.01M -15.9M -12.83M
Capital Expenditures
-179K -1K -13K -221K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-179K -1K -13K -221K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-5.89M -1.87M n/a -3.23M
Financial Cash Flow
68.03M 16.02M n/a 22.52M
Net Cash Flow
48.44M -1.59M -15.71M 9.97M
Free Cash Flow
-19.58M -18.01M -15.91M -13.05M